Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade (original) (raw)

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy

Yufang Shi

Journal of hematology & oncology, 2018

View PDFchevron_right

Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer

Lukas Pfannenstiel

Cancer Immunology Research

View PDFchevron_right

Immune Checkpoints are Important Therapeutic Targets in Cancer Immunotherapy

Shyamali Mukherjee

Cancer Science & Research, 2021

View PDFchevron_right

Immune Checkpoint Blockade: The New Frontier in Cancer Treatment

daniel george

Targeted oncology, 2018

View PDFchevron_right

Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired

Hany Marei

Cancer Cell International

View PDFchevron_right

Immune Checkpoints in Cancers: From Signaling to the Clinic

Robert Ballotti

Cancers, 2021

View PDFchevron_right

Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology

Gboyega Adebami

Global Journal of Cancer Therapy

View PDFchevron_right

Immune checkpoint blockade therapy

Thomas Wieder

The Journal of allergy and clinical immunology, 2018

View PDFchevron_right

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

Kristoffer Rohrberg

Cytotherapy, 2020

View PDFchevron_right

Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy

Yufang Shi

Cellular & molecular immunology, 2018

View PDFchevron_right

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

Ehsan Razeghian

Cell Communication and Signaling, 2022

View PDFchevron_right

Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy

Christopher Nirschl

Clinical Cancer Research, 2013

View PDFchevron_right

Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition

James Reading

Cell, 2021

View PDFchevron_right

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Gordon Freeman

Nature, 2014

View PDFchevron_right

Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation

Evelyn Hutterer

View PDFchevron_right

The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies

Esosa Ukponmwan

Annals of Surgical Oncology, 2018

View PDFchevron_right

Checkpoint blockade in cancer immunotherapy

Alan Korman

Advances in immunology, 2006

View PDFchevron_right

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

Marcin Pasiarski

OncoTargets and Therapy, 2018

View PDFchevron_right

Immune checkpoints in the tumor microenvironment

Neda Khosravi

Seminars in Cancer Biology, 2019

View PDFchevron_right

Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy

James Reading

Immunity, 2016

View PDFchevron_right

Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes

Emanuela Marcenaro

Cancers

View PDFchevron_right

Increasing cure rates of solid tumors by immune checkpoint inhibitors

Tianhong Li

Experimental hematology & oncology, 2023

View PDFchevron_right

Immune checkpoints inhibitors in cancer therapy-current status and future prospects

Rhishika Dutta, Imad Khan, Meghana Sai, Nadeem Siddiqui

International journal of health sciences

View PDFchevron_right

New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials

Yitao Mao

International Journal of Biological Sciences

View PDFchevron_right

Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma

Hans Dieter Nischalke

Cancer Immunology, Immunotherapy, 2019

View PDFchevron_right

Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier

Burhan A Zaman, Somayeh Vafaei

Review, 2022

View PDFchevron_right

A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapy

Arjun Mittra, Cancer Drug Resistance

Cancer Drug Resistance, 2020

View PDFchevron_right

Immune Checkpoint Inhibitors in Cancer Therapy

Mohammad amin Kashani

Current Oncology

View PDFchevron_right

Immune Checkpoint Blockade and Interferon-α in Melanoma

Imran Rafique

Seminars in Oncology, 2015

View PDFchevron_right

Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy

Simran Venkatraman

Vaccines

View PDFchevron_right